Cited by 2,564Atrial Fibrillation Management and OutcomesAcute Ischemic Stroke ManagementHealthcare Systems and Public Health

The DOI matches its Crossref record; 33 of the 35 references it cites were found in a registry or an index.

Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

Miyasaka, Yoko, Barnes, Marion E., Gersh, Bernard J., Cha, Stephen S., Bailey, Kent R., Abhayaratna, Walter P., Seward, James B., Tsang, Teresa S.M.·2006·Circulation

DOI 10.1161/circulationaha.105.595140

Open this paper in CoChat — free account

Abstract

Background— Limited data exist on trends in incidence of atrial fibrillation (AF). We assessed the community-based trends in AF incidence for 1980 to 2000 and provided prevalence projections to 2050. Methods and Results— The adult residents of Olmsted County, Minnesota, who had ECG-confirmed first AF in the period 1980 to 2000 (n=4618) were identified. Trends in age-adjusted incidence were determined and used to construct model-based prevalence estimates. The age- and sex-adjusted incidence of AF per 1000 person-years was 3.04 (95% CI, 2.78 to 3.31) in 1980 and 3.68 (95% CI, 3.42 to 3.95) in 2000. According to Poisson regression with adjustment for age and sex, incidence of AF increased significantly ( P =0.014), with a relative increase of 12.6% (95% CI, 2.1 to 23.1) over 21 years. The increase in age-adjusted AF incidence did not differ between men and women ( P =0.84). According to the US population projections by the US Census Bureau, the number of persons with AF is projected to be 12.1 million by 2050, assuming no further increase in age-adjusted incidence of AF, but 15.9 million if the increase in incidence continues. Conclusions— The age-adjusted incidence of AF increased significantly in Olmsted County during 1980 to 2000. Whether or not this rate of increase continues, the projected number of persons with AF for the United States will exceed 10 million by 2050, underscoring the urgent need for primary prevention strategies against AF development.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.105.595140

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Atrial fibrillation as an independent risk factor for stroke: the Framingham study
Wolf, P. A., Abbott, R. D., & Kannel, W. B. (1991) · Stroke · doi:10.1161/01.str.22.8.983 · Cited by 7,388
Prevalence of Diagnosed Atrial Fibrillation in Adults: National Implications for Rhythm Management and Stroke Prevention: the AnTicoagulation and Risk Factors In Atrial Fibrillation (ATRIA) Study
Go, A. S., Hylek, E. M., Phillips, K. A., Chang, Y., Henault, L. E., Selby, J. V., & Singer, D. E. (2001) · JAMA · doi:10.1001/jama.285.18.2370 · Cited by 6,205
Prevalence and trends in obesity among US adults, 1999–2000
Flegal, K. M. (2002) · JAMA · doi:10.1001/jama.288.14.1723 · Cited by 6,190
Impact of Atrial Fibrillation on the Risk of Death: The Framingham Heart Study
Benjamin, E. J., Wolf, P. A., D’Agostino, R. B., Silbershatz, H., Kannel, W. B., & Levy, D. (1998) · Circulation · doi:10.1161/01.cir.98.10.946 · Cited by 4,575
Burden of Systolic and Diastolic Ventricular Dysfunction in the Community
Redfield, M. M., Jacobsen, S. J., Burnett, J. C. J., Mahoney, D. W., Bailey, K. R., & Rodeheffer, R. J. (2003) · JAMA · doi:10.1001/jama.289.2.194 · Cited by 2,989
Self-citation
Independent Risk Factors for Atrial Fibrillation in a Population-Based Cohort: The Framingham Heart Study
Benjamin, E. J. (1994) · JAMA · doi:10.1001/jama.1994.03510350050036 · Cited by 2,613
Increasing Prevalence of Overweight Among US Adults
Kuczmarski, R. J. (1994) · JAMA · doi:10.1001/jama.272.3.205 · Cited by 2,542
Temporal Relations of Atrial Fibrillation and Congestive Heart Failure and Their Joint Influence on Mortality: The Framingham Heart Study
Wang, T. J., Larson, M. G., Levy, D., Vasan, R. S., Leip, E. P., Wolf, P. A., D’Agostino, R. B., Murabito, J. M., Kannel, W. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000072767.89944.6e · Cited by 1,970
A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study
Stewart, S., Hart, C. L., Hole, D. J., & McMurray, J. J. V. (2002) · The American Journal of Medicine · doi:10.1016/s0002-9343(02)01236-6 · Cited by 1,562
The natural history of atrial fibrillation: Incidence, risk factors, and prognosis in the manitoba follow-up study
Krahn, A. D., Manfreda, J., TATE, R. B., Mathewson, F. A. L., & Cuddy, T. E. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80348-9 · Cited by 1,478

Show all 35 references

Research works printed but not linked: 9

10.1161/circ.84.2.1860192 · DOI
10.1161/str.29.7.1341 · DOI
10.1161/str.22.8.1866765 · DOI
10.1161/str.29.9.1816 · DOI
10.1161/str.28.2.316 · DOI
10.1161/circ.98.10.946 · DOI
10.1016/j.gastro.2005.05.007 · DOI · Paper page
10.1161/circ.96.7.2455 · DOI
10.1001/jama.1994.03520030047027 · DOI

Sorted by citations

Items 501–600 of 1,006

New Directions in Antiarrhythmic Drug Therapy for Atrial Fibrillation
Heijman, J., Voigt, N., & Dobrev, D. (2012) · Future Cardiology · doi:10.2217/fca.12.78 · Cited by 58
2016 ACC/AHA Clinical Performance and Quality Measures for Adults With Atrial Fibrillation or Atrial Flutter
Heidenreich, P. A., Solis, P., Estes, N. A. M., Fonarow, G. C., Jurgens, C. Y., Marine, J. E., McManus, D. D., & McNamara, R. L. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.03.521 · Cited by 58
Thrombogenic and Arrhythmogenic Roles of the Left Atrial Appendage in Atrial Fibrillation
Biase, L. D., Natale, A., & Romero, J. E. (2018) · Circulation · doi:10.1161/circulationaha.118.034187 · Cited by 57
Prior History of Falls and Risk of Outcomes in Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project
Banerjee, A., Clémenty, N., Haguenoer, K., Fauchier, L., & Lip, G. Y. H. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.05.035 · Cited by 57
Evaluation of a Prediction Model for the Development of Atrial Fibrillation in a Repository of Electronic Medical Records
Kolek, M. J., Graves, A. J., Xu, M., Bian, A., Teixeira, P. L., Shoemaker, M. B., Parvez, B., Xu, H., Heckbert, S. R., Ellinor, P. T., et al. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.3366 · Cited by 57
Effectiveness of screening for atrial fibrillation and its determinants. A meta-analysis
Petryszyn, P., Niewiński, P., Staniak, A., Piotrowski, P., Well, A. R., Well, M., Jęśkowiak, I., Lip, G., & Ponikowski, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0213198 · Cited by 50
Clinical Implications of Leaks Following Left Atrial Appendage Ligation With the LARIAT Device
Gianni, C., Biase, L. D., Trivedi, C. G., Mohanty, S., Gökoğlan, Y., Günes, M. F., Bai, R., Al‐Ahmad, A., Burkhardt, J. D., Horton, R., et al. (2016) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2016.01.038 · Cited by 56
Wavelet transform and vector machines as emerging tools for computational medicine
Gupta, V. (2023) · Journal of Ambient Intelligence and Humanized Computing · doi:10.1007/s12652-023-04582-0 · Cited by 56
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards
Marcucci, M., Iorio, A., Nobili, A., Tettamanti, M., Pasina, L., Marengoni, A., Salerno, F., Corrao, S., & Mannucci, P. M. (2010) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2010.07.014 · Cited by 55
Termination of sustained atrial flutter and fibrillation using low-voltage multiple-shock therapy
Ambrosi, C. M., Ripplinger, C. M., Efimov, I. R., & Fedorov, V. V. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2010.10.018 · Cited by 56
Net Clinical Benefit of Warfarin Therapy in Elderly Chinese Patients With Atrial Fibrillation
Siu, C., & Tse, H. (2014) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.113.000858 · Cited by 56
The significance of preoperative atrial fibrillation in patients undergoing cardiac surgery: preoperative atrial fibrillation--still underestimated opponent
Banach, M., Mariscalco, G., Uğurlucan, M., Mikhailidis, D. P., Barylski, M., & Rysz, J. (2008) · EP Europace · doi:10.1093/europace/eun273 · Cited by 56
Left Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke
Maheshwari, A., Norby, F. L., Inciardi, R. M., Wang, W., Zhang, M. J., Soliman, E. Z., Alonso, Á., Johansen, M. C., Gottesman, R. F., Solomon, S. D., et al. (2022) · Annals of Internal Medicine · doi:10.7326/m22-1638 · Cited by 55
Atrial Fibrillation Hospitalization Is Not Increased with Short‐Term Elevations in Exposure to Fine Particulate Air Pollution
Bunch, T. J., Horne, B. D., Asirvatham, S. J., DAY, J. D., Crandall, B. G., Weiss, J. P., Osborn, J. S., Anderson, J. L., Muhlestein, J. B., LAPPE, D. L., et al. (2011) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03200.x · Cited by 55
Gastroparesis as a Complication of Atrial Fibrillation Ablation
Aksu, T., Gölcük, Ş. E., Güler, T. E., Yalın, K., & Erden, İ. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.03.045 · Cited by 55
Usefulness of Dabigatran Etexilate as Periprocedural Anticoagulation Therapy for Atrial Fibrillation Ablation
Yamaji, H., Murakami, T., Hina, K., Higashiya, S., Kawamura, H., Murakami, M., Kamikawa, S., Hirohata, S., & Kusachi, S. (2013) · Clinical Drug Investigation · doi:10.1007/s40261-013-0081-1 · Cited by 55
Low-Energy Multistage Atrial Defibrillation Therapy Terminates Atrial Fibrillation With Less Energy Than a Single Shock
Li, W., Janardhan, A. H., Fedorov, V. V., Sha, Q., Schuessler, R. B., & Efimov, I. R. (2011) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.111.965830 · Cited by 55
Relation of Obesity to New-Onset Atrial Fibrillation and Atrial Flutter in Adults
Foy, A., Mandrola, J. M., Liu, G., & Naccarelli, G. V. (2018) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2018.01.019 · Cited by 56
Validation of the Framingham Heart Study and CHARGE-AF Risk Scores for Atrial Fibrillation in Hispanics, African-Americans, and Non-Hispanic Whites
Shulman, E. H., Kargoli, F., Aagaard, P., Hoch, E. G., Biase, L. D., Fisher, J., GROSS, J. N., Kim, S., KRUMERMAN, A. K., & Ferrick, K. J. (2015) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2015.10.009 · Cited by 54
Incidence, prevalence, and antithrombotic management of atrial fibrillation in elderly Germans
Ohlmeier, C., Mikolajczyk, R., Haverkamp, W., & Garbe, E. (2013) · EP Europace · doi:10.1093/europace/eut048 · Cited by 54
Factors Associated With the Epidemic of Hospitalizations Due to Atrial Fibrillation
Wong, C. X. J., Brooks, A. G., Lau, D. H., Leong, D. P., Sun, M. T., Sullivan, T., Roberts‐Thomson, K. C., & Sanders, P. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.07.011 · Cited by 54
Effects of statin therapy on preventing atrial fibrillation in coronary disease and heart failure
Adabağ, S., Nelson, D. B., & Bloomfield, H. E. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.07.018 · Cited by 54
Atrial Fibrillation Patients Treated With Long‐Term Warfarin Anticoagulation Have Higher Rates of All Dementia Types Compared With Patients Receiving Long‐Term Warfarin for Other Indications
Bunch, T. J., May, H. T., Bair, T. L., Crandall, B. G., Cutler, M. J., Day, J. D., Jacobs, V., Mallender, C. D., Osborn, J. S., Stevens, S. M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.003932 · Cited by 59
Divergent Temporal Trends in Morbidity and Mortality Related to Heart Failure and Atrial Fibrillation: Age, Sex, Race, and Geographic Differences in the United States, 1991–2015
Vasan, R. S., Zuo, Y., & Kalesan, B. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.118.010756 · Cited by 54
Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy
Straube, F., Dorwarth, U., Vogt, J., Kuniss, M., Kück, K., Tebbenjohanns, J., Garcı́a-Alberola, A., Chun, K. R. J., Souza, J. J., Ouarrak, T., et al. (2014) · EP Europace · doi:10.1093/europace/euu162 · Cited by 53
Incidence and Risk Factors for Atrial Fibrillation in Korea: the National Health Insurance Service Database (2002–2010)
Son, M. K., Lim, N.-K., Cho, M., & Park, H. (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.4.515 · Cited by 53
Incidence and Mortality Trends of Atrial Fibrillation/Atrial Flutter in the United States 1990 to 2017
DeLago, A. J., Essa, M., Ghajar, A., Hammond‐Haley, M., Parvez, A., Nawaz, I., Shalhoub, J., Marshall, D. C., Nazarian, S., Calkins, H. G., et al. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.02.014 · Cited by 53
Cannabis, cocaine, methamphetamine, and opiates increase the risk of incident atrial fibrillation
Lin, A. L., Nah, G., Tang, J. J., Vittinghoff, E., Dewland, T. A., & Marcus, G. M. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac558 · Cited by 54
Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke
Viles-González, J. F., Reddy, V. Y., Petrů, J., Mráz, T., Grossova, Z., Královec, Š., & Neužil, P. (2011) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-011-9613-x · Cited by 53
Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark
Langkilde, L. K., Asmussen, M. B., & Overgaard, M. (2012) · Journal of Medical Economics · doi:10.3111/13696998.2012.673525 · Cited by 52
Red Blood Cell Distribution Width is a Biomarker of Red Cell Dysfunction Associated with High Systemic Inflammation and a Prognostic Marker in Heart Failure and Cardiovascular Disease: A Potential Predictor of Atrial Fibrillation Recurrence
García‐Escobar, A., Lázaro-García, R., Goicolea-Ruigómez, J., González‐Casal, D., Fontenla, A., Soto, N., González‐Panizo, J., Datino, T., Pizarro, G., Moreno, R., et al. (2024) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-024-00662-0 · Cited by 58
Outcomes After Kidney Transplantation of Patients Previously Diagnosed With Atrial Fibrillation
Lenihan, C. R., Montez‐Rath, M. E., Scandling, J. D., Turakhia, M. P., & Winkelmayer, W. C. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12197 · Cited by 54
Association of Smoking, Alcohol, and Obesity with Cardiovascular Death and Ischemic Stroke in Atrial Fibrillation: The Atherosclerosis Risk in Communities (ARIC) Study and Cardiovascular Health Study (CHS)
Kwon, Y., Norby, F. L., Jensen, P. N., Agarwal, S. K., Soliman, E. Z., Lip, G. Y. H., Longstreth, W. T., Alonso, Á., Heckbert, S. R., & Chen, L. Y. (2016) · PLoS ONE · doi:10.1371/journal.pone.0147065 · Cited by 52
Identification of Incident Atrial Fibrillation From Electronic Medical Records
Chamberlain, A. M., Roger, V. L., Noseworthy, P. A., Chen, L. Y., Weston, S. A., Jiang, R., & Alonso, Á. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.023237 · Cited by 51
Metabolic syndrome, atrial fibrillation, and stroke: Tackling an emerging epidemic
Hajhosseiny, R., Matthews, G. D. K., & Lip, G. Y. H. (2015) · Heart Rhythm · doi:10.1016/j.hrthm.2015.06.038 · Cited by 53
Alendronate and atrial fibrillation: a meta-analysis of randomized placebo-controlled clinical trials
Barrett-Connor, E. L., Swern, A. S., Hustad, C. M., Bone, H., Liberman, U. A., Papapoulos, S. E., Wang, H., de Papp, A., & Santora, A. C. (2011) · Osteoporosis International · doi:10.1007/s00198-011-1546-9 · Cited by 49
Measuring Quality of Oral Anticoagulation Care: Extending Quality Measurement to a New Field
Rose, A. J., Berlowitz, D. R., Frayne, S. M., & Hylek, E. M. (2009) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(09)35019-9 · Cited by 51
Left Ventricular Systolic Dysfunction by Longitudinal Strain Is an Independent Predictor of Incident Atrial Fibrillation
Russo, C. A., Jin, Z., Sera, F., Lee, E. S., Homma, S., Rundek, T., Elkind, M. S. V., Sacco, R. L., & Tullio, M. R. D. (2015) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003520 · Cited by 51
Asian strategy for stroke prevention in atrial fibrillation
Chiang, C., Wang, K.-L., & Lin, S. (2015) · EP Europace · doi:10.1093/europace/euv231 · Cited by 51
Risk Score for Prediction of 10-Year Atrial Fibrillation: A Community-Based Study
Aronson, D., Shalev, V., Katz, R., Chodick, G., & Mutlak, D. (2018) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1668522 · Cited by 53
Aging, Obesity, and the Incidence of Diverticulitis: A Population-Based Study
Lee, T. H., Setty, P. T., Parthasarathy, G., Bailey, K. R., Wood‐Wentz, C. M., Fletcher, J. G., Takahashi, N., Khosla, S., Moynagh, M. R., Zinsmeister, A. R., et al. (2018) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2018.03.005 · Cited by 51
Self-citation
Autonomic nervous system and cardiac neuro-signaling pathway modulation in cardiovascular disorders and Alzheimer’s disease
Elia, A., & Fossati, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060666 · Cited by 55
Effect of Screening for Undiagnosed Atrial Fibrillation on Stroke Prevention
Lópes, R. D., Atlas, S. J., Go, A. S., Lubitz, S. A., McManus, D. D., Dolor, R. J., Chatterjee, R., Rothberg, M. B., Rushlow, D. R., Crosson, L. A., et al. (2024) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2024.08.019 · Cited by 50
Effect of Lenient Versus Strict Rate Control on Cardiac Remodeling in Patients With Atrial Fibrillation
Smit, M. D., Crijns, H. J. G. M., Tijssen, J. G. P., Hillege, H. L., Alings, M., Tuininga, Y. S., Groenveld, H. F., van den Berg, M. P., van Veldhuisen, D. J., & Gelder, I. C. V. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.04.030 · Cited by 50
Atrial fibrillation and obesity among older Chinese: The Guangzhou Biobank Cohort Study
Long, M. J., Jiang, C. Q., Lam, T. H., Xu, L., Zhang, W. S., Lin, J. M., Ou, J. P., & Cheng, K. K. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2009.10.022 · Cited by 50
Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated geneGREM2regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm
Müller, I. I., Melville, D. B., Tanwar, V., Rybski, W. M., Mukherjee, A., Shoemaker, B. M., Wang, W.-D., Schoenhard, J. A., Roden, D. M., Darbar, D., et al. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.010488 · Cited by 49
Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
Sanoski, C. A. (2009) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2009.15.s6-b.4 · Cited by 50
Effect of Intensive Blood Pressure Lowering on Incident Atrial Fibrillation and P-Wave Indices in the ACCORD Blood Pressure Trial
Chen, L. Y., Bigger, J. T., Hickey, K. T., Chen, H., Lopez-Jimenez, C., Banerji, M. A., Evans, G. W., Fleg, J. L., Papademetriou, V., Thomas, A., et al. (2015) · American Journal of Hypertension · doi:10.1093/ajh/hpv172 · Cited by 51
Atrial fibrillation in young patients
Gourraud, J., Khairy, P., Abadir, S., Tadros, R., Cadrin‐Tourigny, J., Macle, L., Dyrda, K., Mondesert, B. A., Dubuc, M., Guerra, P. G., et al. (2018) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2018.1490644 · Cited by 50
P Wave Indices—Advancing Our Understanding of Atrial Fibrillation-Related Cardiovascular Outcomes
Chen, L. Y., & Soliman, E. Z. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00053 · Cited by 54
Prevalence and incidence rates of atrial fibrillation in Norway 2004–2014
Kjerpeseth, L. J., Igland, J., Selmer, R., Ellekjær, H., Tveit, A., Berge, T., Kalstø, S. M., Christophersen, I. E., Myrstad, M., Skovlund, E., et al. (2021) · Heart · doi:10.1136/heartjnl-2020-316624 · Cited by 50
Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms
Geng, M., Lin, A., & Nguyen, T. P. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.581837 · Cited by 54
Management of atrial fibrillation in older adults
Parks, A. L., Frankel, D. S., Kim, D. H., Ko, D., Kramer, D. B., Lydston, M., Fang, M. C., & Shah, S. J. (2024) · BMJ · doi:10.1136/bmj-2023-076246 · Cited by 61
Prevalence of atrial fibrillation in China and its risk factors.
Li, Y., Wu, Y., Chen, K. P., Li, X., Zhang, X., Xie, G. Q., Wang, F. Z., & Zhang, S. (2013) · PubMed · doi:10.3967/0895-3988.2013.09.001 · Cited by 50
A national survey of the management of atrial fibrillation with antithrombotic drugs in Italian primary care
Filippi, A., Alacqua, M., Cowell, W., Shakespeare, A., Mantovani, L. G., Bianchi, C., Cricelli, C. A., & Mazzaglia, G. (2010) · Thrombosis and Haemostasis · doi:10.1160/th09-08-0525 · Cited by 49
Antihypertensive Treatment With ACE Inhibitors or -Blockers and Risk of Incident Atrial Fibrillation in a General Hypertensive Population
Heckbert, S. R., Wiggins, K. L., Glazer, N. L., Dublin, S., Psaty, B. M., Smith, N., Longstreth, W. T., & Lumley, T. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.33 · Cited by 48
Don’t add aspirin for associated stable vascular disease in a patient with atrial fibrillation receiving anticoagulation
Lip, G. Y. H. (2008) · BMJ · doi:10.1136/bmj.39351.706586.ad · Cited by 49
Associations of obesity and body fat distribution with incident atrial fibrillation in the biracial health aging and body composition cohort of older adults
Aronis, K. N., Wang, N., Phillips, C. L., Benjamin, E. J., Marcus, G. M., Newman, A. B., Rodondi, N., Satterfield, S., Harris, T. B., & Magnani, J. W. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.06.007 · Cited by 49
Percent Time With a Supratherapeutic INR in Atrial Fibrillation Patients Also Using an Antiplatelet Agent Is Associated With Long‐Term Risk of Dementia
Jacobs, V., Woller, S. C., Stevens, S. M., May, H. T., Bair, T. L., Crandall, B. G., Cutler, M. J., DAY, J. D., Weiss, J. P., Osborn, J. S., et al. (2015) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12776 · Cited by 48
Diabetes and thyroid hormones affect connexin-43 and PKC-ε expression in rat heart atria
Mitašíková, M., Lin, H., Soukup, T., Imanaga, I., & Tribulová, N. (2009) · Physiological Research · doi:10.33549/physiolres.931425 · Cited by 49
Deep learning of left atrial structure and function provides link to atrial fibrillation risk
Pirruccello, J. P., Achille, P. D., Choi, S. H., Rämö, J. T., Khurshid, S. S., Nekoui, M., Jurgens, S. J., Nauffal, V., Kany, S., FinnGen, et al. (2024) · Nature Communications · doi:10.1038/s41467-024-48229-w · Cited by 52
Atrioventricular junction ablation combined with either right ventricular pacing or cardiac resynchronization therapy for atrial fibrillation: The need for large-scale randomized trials
Bradley, D. J., & Shen, W.-K. (2006) · Heart Rhythm · doi:10.1016/j.hrthm.2006.10.016 · Cited by 49
Prevalence and spectrum of Nkx2.5 mutations associated with idiopathic atrial fibrillation
Xie, W.-H., Chang, C., Xu, Y., Li, R., Qu, X., Fang, W., Liu, X., & Yang, Y. (2013) · Clinics · doi:10.6061/clinics/2013(06)09 · Cited by 48
Atrial fibrillation is a possible marker of frailty in hospitalized patients: results of the GIFA Study
Fumagalli, S., Tarantini, F., Guarducci, L., Pozzi, C., Pepe, G., Boncinelli, L., Valoti, P., Baldasseroni, S., Masotti, G., & Marchionni, N. (2010) · Aging Clinical and Experimental Research · doi:10.1007/bf03324785 · Cited by 48
Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry
Lip, G. Y. H., Laroche, C., Boriani, G., Dan, G., Santini, M., Kalarus, Z. F., Rasmussen, L. H., Oliveira, M., Mairesse, G. H., Crijns, H. J. G. M., et al. (2014) · EP Europace · doi:10.1093/europace/euu201 · Cited by 48
High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme
Sandhu, R. K., Dolovich, L. R., Deif, B., Barake, W. M., Agarwal, G., Grinvalds, A., Lim, T., Quinn, F. R., Gladstone, D. J., Conen, D., et al. (2016) · Open Heart · doi:10.1136/openhrt-2016-000515 · Cited by 48
Left Atrial Appendage Occlusion Eliminates the Need for Warfarin
Holmes, D. R., & Schwartz, R. S. (2009) · Circulation · doi:10.1161/circulationaha.108.844761 · Cited by 48
Comprehensive nationwide incidence and prevalence trends of atrial fibrillation in Finland
Lehto, M., Haukka, J. K., Aro, A. L., Halminen, O., Jukka Putaala, A., Linna, M., Mustonen, P. E., Kinnunen, J., Kouki, E., Niiranen, J., et al. (2022) · Open Heart · doi:10.1136/openhrt-2022-002140 · Cited by 47
Mitochondrial Dysfunction in Cardiac Arrhythmias
Deng, J., Jiang, Y., Chen, Z. B., Rhee, J., Deng, Y., & Wang, Z. V. (2023) · Cells · doi:10.3390/cells12050679 · Cited by 53
Predictors of Warfarin Use in Atrial Fibrillation Patients in the Inpatient Setting
Agarwal, S., Bennett, D., & Smith, D. J. (2010) · American Journal of Cardiovascular Drugs · doi:10.2165/11318870-000000000-00000 · Cited by 47
Annual Incidence of Atrial Fibrillation and Related Factors in Adults
Iguchi, Y., Kimura, K., Shibazaki, K., Aoki, J., Kobayashi, K., Sakai, K., & Sakamoto, Y. (2010) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2010.06.030 · Cited by 47
Effect of Race/Ethnicity on the Efficacy of Warfarin
Shen, A. Y., Chen, W., Yao, J. F., Brar, S. S., Wang, X., & Go, A. S. (2008) · CNS Drugs · doi:10.2165/00023210-200822100-00003 · Cited by 47
Examining warfarin underutilization rates in patients with atrial fibrillation: Detailed chart review essential to capture contraindications to warfarin therapy
Srivastava, A., Hudson, M. P., Hamoud, I., Cavalcante, J. L., Pai, C., & Kaatz, S. S. (2008) · Thrombosis Journal · doi:10.1186/1477-9560-6-6 · Cited by 47
The Aging Heart: A Molecular and Clinical Challenge
Lazzeroni, D., Villatore, A., Souryal, G., Pili, G., & Peretto, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416033 · Cited by 52
Galectin-3 and incidence of atrial fibrillation: The Atherosclerosis Risk in Communities (ARIC) study
Fashanu, O. E., Norby, F. L., Aguilar, D., Ballantyne, C. M., Hoogeveen, R. C., Chen, L. Y., Soliman, E. Z., Alonso, A., & Folsom, A. R. (2017) · American Heart Journal · doi:10.1016/j.ahj.2017.07.001 · Cited by 50
Clinical Use of Rivaroxaban: Pharmacokinetic and Pharmacodynamic Rationale for Dosing Regimens in Different Indications
Trujillo, T. C., & Dobesh, P. P. (2014) · Drugs · doi:10.1007/s40265-014-0278-5 · Cited by 48
Warfarin Versus New Agents: Interpreting the Data
Ansell, J. (2010) · Hematology · doi:10.1182/asheducation-2010.1.221 · Cited by 46
Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial
Latini, R., Staszewsky, L. I., Sun, J., Bethel, M. A., Disertori, M., Haffner, S. M., Holman, R. R., Chang, F., Giles, T. D., Maggioni, A. P., et al. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.08.012 · Cited by 48
Understanding Atrial Fibrillation: The Signal Processing Contribution, Part II
Mainardi, L., Sörnmo, L., & Cerutti, S. (2008) · Synthesis lectures on biomedical engineering · doi:10.2200/s00153ed1v01y200809bme025 · Cited by 47
Real-world characteristics of hospitalized frail elderly patients with atrial fibrillation: can we improve the current prescription of anticoagulants?
Annoni, G., & Mazzola, P. (2016) · PubMed Central · doi:10.11909/j.issn.1671-5411.2016.03.010 · Cited by 46
The Impact of First Procedure Success Rate on the Economics of Atrial Fibrillation Ablation
MANSOUR, M. C., Karst, E., Heist, E. K., Dalal, N., Wasfy, J. H., Packer, D. L., Calkins, H. G., Ruskin, J. N., & Mahapatra, S. (2016) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2016.06.002 · Cited by 47
Refining Prediction of Atrial Fibrillation Risk in the General Population With Analysis of P-Wave Axis (from the Atherosclerosis Risk in Communities Study)
Maheshwari, A., Norby, F. L., Soliman, E. Z., Koene, R. J., Rooney, M. R., O’Neal, W. T., Alonso, Á., & Chen, L. Y. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.08.015 · Cited by 46
Ambulatory blood pressure and long-term risk for atrial fibrillation
Tikhonoff, V., Kuznetsova, T., Thijs, L., Cauwenberghs, N., Stolarz‐Skrzypek, K., Seidlerová, J., Malyutina, S. K., Gilis‐Malinowska, N., Świerblewska, E., Kawecka−Jaszcz, K., et al. (2018) · Heart · doi:10.1136/heartjnl-2017-312488 · Cited by 48
Rebleeding vs Thromboembolism After Hospitalization for Gastrointestinal Bleeding in Patients on Direct Oral Anticoagulants
Sengupta, N., Marshall, A. L., Jones, B. A., Ham, S. A., & Tapper, E. B. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.05.005 · Cited by 48
Effects of the short‐term exposure to ambient air pollution on atrial fibrillation
Liu, X., Kong, D., Liu, Y., Fu, J., Gao, P., Chen, T., Fang, Q., Cheng, K., & Fan, Z. (2018) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.13500 · Cited by 45
Comprehensive metabolomic and proteomic analyses reveal candidate biomarkers and related metabolic networks in atrial fibrillation
Zhou, J., Sun, L., Chen, L., Liu, S., Zhong, L., & Cui, M. (2019) · Metabolomics · doi:10.1007/s11306-019-1557-7 · Cited by 44
Genetics of Atrial Fibrillation
Lubitz, S. A., Yi, B. A., & Ellinor, P. T. (2010) · Heart Failure Clinics · doi:10.1016/j.hfc.2009.12.004 · Cited by 46
Persistent atrial fibrillation: current approach and controversies
Parkash, R., Verma, A., & Tang, A. (2009) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e3283336d52 · Cited by 45
Prevalence of atrial fibrillation in Asia and the world
Kodani, E., & Atarashi, H. (2012) · Journal of Arrhythmia · doi:10.1016/j.joa.2012.07.001 · Cited by 45
Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries
Holstenson, E., Ringborg, A., Lindgren, P., Coste, F., Diamand, F., Nieuwlaat, R., & Crijns, H. J. G. M. (2010) · EP Europace · doi:10.1093/europace/euq325 · Cited by 45
Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice
Go, A. S., Singer, D. E., Toh, S., Cheetham, T. C., Reichman, M. E., Graham, D. J., Southworth, M. R., Zhang, R., Izem, R., Goulding, M. R., et al. (2017) · Annals of Internal Medicine · doi:10.7326/m16-1157 · Cited by 47
Hospital and clinical care costs associated with atrial fibrillation for Medicare beneficiaries in the Cardiovascular Health Study and the Framingham Heart Study
Delaney, J. A., Yin, X., Fontes, J. D., Wallace, E. R., Skinner, A. C., Wang, N., Hammill, B. G., Benjamin, E. J., Curtis, L. H., & Heckbert, S. R. (2018) · SAGE Open Medicine · doi:10.1177/2050312118759444 · Cited by 45
Low‐Carbohydrate Diets and Risk of Incident Atrial Fibrillation: A Prospective Cohort Study
Zhang, S., Zhuang, X., Lin, X., Zhong, X., Zhou, H., Sun, X., Xiong, Z., Huang, Y., Fan, Y., Guo, Y., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.011955 · Cited by 51
Efficacy and Safety of Nonvitamin K Oral Anticoagulants in Patients with Atrial Fibrillation and Cancer: A Study-Level Meta-Analysis
Cavallari, I., Verolino, G., Romano, S., & Patti, G. (2019) · Thrombosis and Haemostasis · doi:10.1055/s-0039-3400300 · Cited by 45
Prevention of Cardioembolic Stroke
Freeman, W. D., & Aguilar, M. I. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0048-y · Cited by 45
Peri-procedural management of patients taking oral anticoagulants
Daniels, P. R. (2015) · BMJ · doi:10.1136/bmj.h2391 · Cited by 46
Review Article: Gastrointestinal Bleeding Risk with Direct Oral Anticoagulants
Benamouzig, R., Guenoun, M., Deutsch, D., & Fauchier, L. (2021) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-021-07211-0 · Cited by 49
Atrial Fibrillation: Pathophysiology and Therapeutic Options
Bhatt, H. V., & Fischer, G. W. (2015) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2015.05.058 · Cited by 51
Home Management of Oral Anticoagulation via Telemedicine Versus Conventional Hospital-Based Treatment
Christensen, H., Lauterlein, J.-J., Sørensen, P. D., Petersen, E. R. B., Madsen, J. S., & Brandslund, I. (2011) · Telemedicine Journal and e-Health · doi:10.1089/tmj.2010.0128 · Cited by 44
Impact of weight reduction on pericardial adipose tissue and cardiac structure in patients with atrial fibrillation.
Abed, H., Nelson, A., Richardson, J., Worthley, S., Vincent, A., Wittert, G., & Leong, D. (2015) · American Heart Journal · doi:10.1016/j.ahj.2015.02.008 · Cited by 49

Authors: Miyasaka, Y., Barnes, M. E., Gersh, B. J., Cha, S. S., Bailey, K. R., Abhayaratna, W. P., Seward, J. B., & Tsang, T. S. M.
Affiliations: Mayo Clinic (US)
ORCID: Miyasaka, Yoko
Barnes, Marion E.
Gersh, Bernard J.
Bailey, Kent R.
Abhayaratna, Walter P.
Tsang, Teresa S.M.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2006-07-11
Volume: 114
Issue: 2
Pages: 119-125
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.105.595140
OpenAlex: W2141889414
Cited by: 2,564
References: 35
Citations by year: 2026: 43 · 2025: 63 · 2024: 99 · 2023: 92 · 2022: 127 · 2021: 116 · 2020: 122 · 2019: 120 · 2018: 140 · 2017: 153 · 2016: 150 · 2015: 201 · 2014: 189 · 2013: 229 · 2012: 200
FWCI: 56.63
Type: journal article
Language: en
Update notices: correction (2006-09-12)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Funders: National Institute on Aging (R01 AG22070, R01AG022070)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Atrial Fibrillation Management and Outcomes
Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords: atrial fibrillation, incidence trends, prevalence projections, age-adjusted incidence, sex differences, Olmsted County, Minnesota, primary prevention, population projections
MeSH terms: Adult, Age Factors, Atrial Fibrillation, Electrocardiography, Female, Humans, Male, Medical Records, Minnesota, Obesity, United States, Incidence, Prevalence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future Prevalence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks